Clusters of cognitive and behavioral disorders clearly distinguish primary progressive aphasia from frontal lobe dementia, and Alzheimer's disease.

PubWeight™: 0.93‹?›

🔗 View Article (PMID 17851236)

Published in Dement Geriatr Cogn Disord on September 12, 2007

Authors

C Marra1, D Quaranta, M Zinno, S Misciagna, A Bizzarro, C Masullo, A Daniele, G Gainotti

Author Affiliations

1: Neuropsychology Service of the Catholic University of Rome, Policlinico Gemelli, Rome, Italy. cmarra@rm.unicatt.it

Articles by these authors

The Mental Deterioration Battery: normative data, diagnostic reliability and qualitative analyses of cognitive impairment. The Group for the Standardization of the Mental Deterioration Battery. Eur Neurol (1996) 2.97

Emotional behavior and hemispheric side of the lesion. Cortex (1972) 2.29

EFNS guidelines for the diagnosis and management of Alzheimer's disease. Eur J Neurol (2010) 2.21

Fibrinogen apheresis in the treatment of peripheral arterial disease. Blood Purif (2007) 2.18

Amphotericin B treatment dissociates in vivo replication of the scrapie agent from PrP accumulation. Nature (1992) 2.11

Levels of adrenocortical autoantibodies correlate with the degree of adrenal dysfunction in subjects with preclinical Addison's disease. J Clin Endocrinol Metab (1998) 1.68

Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-95. European Union (EU) Collaborative Study Group of Creutzfeldt-Jakob disease (CJD). Lancet (1998) 1.60

Qualitative analysis of unilateral spatial neglect in relation to laterality of cerebral lesions. J Neurol Neurosurg Psychiatry (1972) 1.57

Zolpidem in Parkinson's disease. Lancet (1997) 1.57

Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology (1994) 1.50

Motor cortex hyperexcitability to transcranial magnetic stimulation in Alzheimer's disease. J Neurol Neurosurg Psychiatry (2004) 1.46

Cognitive outcome 5 years after bilateral chronic stimulation of subthalamic nucleus in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (2006) 1.44

Sulphate polyanions prolong the incubation period of scrapie-infected hamsters. J Gen Virol (1992) 1.42

Brain perfusion abnormalities in Alzheimer's disease: comparison between patients with focal temporal lobe dysfunction and patients with diffuse cognitive impairment. J Neurol Neurosurg Psychiatry (2001) 1.40

Amphotericin B delays the incubation period of scrapie in intracerebrally inoculated hamsters. J Gen Virol (1987) 1.39

Noninvasive in vivo assessment of cholinergic cortical circuits in AD using transcranial magnetic stimulation. Neurology (2002) 1.32

Validity of some neuropsychological tests in the assessment of mental deterioration. Acta Psychiatr Scand (1979) 1.27

Cerebellum and procedural learning: evidence from focal cerebellar lesions. Brain (1997) 1.25

Correlations between peripheral blood mononuclear cell production of BDNF, TNF-alpha, IL-6, IL-10 and cognitive performances in multiple sclerosis patients. J Neurosci Res (2010) 1.23

Comprehension of symbolic gestures in aphasia. Brain Lang (1976) 1.23

Transmission of Creutzfeldt-Jakob disease by dural cadaveric graft. J Neurosurg (1989) 1.21

Serum antibodies to collagen XIII: a further good marker of active Graves' ophthalmopathy. Clin Endocrinol (Oxf) (2005) 1.19

EFNS-ENS Guidelines on the diagnosis and management of disorders associated with dementia. Eur J Neurol (2012) 1.19

Some aspects of phonological impairment in aphasia. Brain Lang (1980) 1.16

European surveillance on Creutzfeldt-Jakob disease: a case-control study for medical risk factors. J Clin Epidemiol (2000) 1.14

Mechanisms of unilateral spatial neglect in relation to laterality of cerebral lesions. Brain (1986) 1.11

Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter's syndrome. J Clin Endocrinol Metab (1987) 1.09

Evidence for a possible neuroanatomical basis for lexical processing of nouns and verbs. Neuropsychologia (1994) 1.06

Apolipoprotein E epsilon4 allele differentiates the clinical response to donepezil in Alzheimer's disease. Dement Geriatr Cogn Disord (2005) 1.04

Peripheral neuropathy in the course of progressive systemic sclerosis: light and ultrastructural study. Ital J Neurol Sci (1982) 1.04

Neuroanatomical correlates of category-specific semantic disorders: a critical survey. Memory (1996) 1.04

Zolpidem in progressive supranuclear palsy. N Engl J Med (1999) 1.02

A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease. Ann Neurol (1993) 1.01

Neuropsychological correlates of localized cerebral lesions in non-aphasic brain-damaged patients. J Clin Neuropsychol (1981) 1.01

The relationship between visuospatial and representational neglect. Neurology (1994) 1.01

Gonadal steroids modulate human monocyte interleukin-1 (IL-1) activity. Fertil Steril (1988) 1.00

Time course of 21-hydroxylase antibodies and long-term remission of subclinical autoimmune adrenalitis after corticosteroid therapy: case report. J Clin Endocrinol Metab (2001) 0.99

Remission of subclinical adrenocortical failure in subjects with adrenal autoantibodies. J Clin Endocrinol Metab (1993) 0.99

Hunter syndrome: presence of material cross-reacting with antibodies against iduronate sulfatase. Hum Genet (1987) 0.98

Cloning of cDNA for a novel mouse membrane glycoprotein (gp42): shared identity to histocompatibility antigens, immunoglobulins and neural-cell adhesion molecules. Gene (1989) 0.98

Early rightwards orienting of attention on simple reaction time performance in patients with left-sided neglect. Neuropsychologia (1992) 0.98

Selective deficit for people's names following left temporal damage: an impairment of domain-specific conceptual knowledge. Cogn Neuropsychol (2000) 0.96

Longitudinal study of vasopressin-cell antibodies and of hypothalamic-pituitary region on magnetic resonance imaging in patients with autoimmune and idiopathic complete central diabetes insipidus. J Clin Endocrinol Metab (2002) 0.96

Pattern of ipsilateral clinical extinction in brain-damaged patients. Appl Neurophysiol (1975) 0.96

Neurophysiological predictors of long term response to AChE inhibitors in AD patients. J Neurol Neurosurg Psychiatry (2005) 0.95

Visuospatial abilities in cerebellar disorders. J Neurol Neurosurg Psychiatry (2004) 0.95

In vivo cholinergic circuit evaluation in frontotemporal and Alzheimer dementias. Neurology (2006) 0.94

Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease. Neurology (2009) 0.92

Polymorphisms of the prion protein gene in Italian patients with Creutzfeldt-Jakob disease. Hum Genet (1994) 0.92

Creutzfeldt-Jakob disease after non-commercial dura mater graft. Lancet (1992) 0.91

Failure to ameliorate Creutzfeldt-Jakob disease with amphotericin B therapy. J Infect Dis (1992) 0.91

MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer. Anticancer Res (2007) 0.91

Contralateral and ipsilateral tactile extinction in patients with right and left focal brain damage. Int J Neurosci (1989) 0.90

Involvement of hypothalamus autoimmunity in patients with autoimmune hypopituitarism: role of antibodies to hypothalamic cells. J Clin Endocrinol Metab (2012) 0.90

A quantitative study of the "closing-in" symptom in normal children and in brain-damaged patients. Neuropsychologia (1972) 0.90

Pseudotumor cerebri as presenting syndrome of Addisonian crisis. Ital J Neurol Sci (1995) 0.89

The influence of the hemispheric side of lesion on non verbal tasks of finger localization. Cortex (1972) 0.89

Oxidative stress and overexpression of manganese superoxide dismutase in patients with Alzheimer's disease. Neurosci Lett (1998) 0.89

Naming deficit for non-living items: neuropsychological and PET study. Neuropsychologia (1997) 0.88

Pretreatment neuropsychological deficits in children with brain tumors. Neuro Oncol (2011) 0.88

Cognitive impairment in myotonic dystrophy type 1 (DM1): a longitudinal follow-up study. J Neurol (2008) 0.87

Constructional apraxia and visuoperceptive disabilities in relation to laterality of cerebral lesions. Cortex (1978) 0.86

Experimental drug treatment of scrapie: a pathogenetic basis for rationale therapeutics. Eur J Epidemiol (1991) 0.86

The missing ApoE allele. Ann Hum Genet (2007) 0.86

Patterns of drawing disability in right and left hemispheric patients. Neuropsychologia (1970) 0.86

Some anatomo-clinical aspects of phonemic and semantic comprehension disorders in aphasia. Acta Neurol Scand (1982) 0.86

Predictors of cognitive decline in the early stage of probable Alzheimer's disease. Dement Geriatr Cogn Disord (2000) 0.86

Dissociation between knowledge of living and nonliving things in dementia of the Alzheimer type. Neurology (1991) 0.86

Detection of vasopressin cell antibodies in some patients with autoimmune endocrine diseases without overt diabetes insipidus. Clin Endocrinol (Oxf) (1994) 0.85

Neurophysiological study of normal pressure hydrocephalus. Acta Psychiatr Scand (1982) 0.85

Right side neglect in right cerebellar lesion. J Neurol Neurosurg Psychiatry (2001) 0.85

Alzheimer disease risk associated with APOE4 is modified by STH gene polymorphism. Neurology (2004) 0.84

Ovulation induction with human menopausal gonadotropin compared to human urinary follicle-stimulating hormone results in a significant shift in follicular fluid androgen levels without discernible differences in granulosa-luteal cell function. J Clin Endocrinol Metab (1986) 0.84

Heparan N-sulfatase gene: two novel mutations and transient expression of 15 defects. Biochim Biophys Acta (2000) 0.84

The relationship between type of naming error and semantic-lexical discrimination in aphasic patients. Cortex (1981) 0.83

The role of brain infarcts and hippocampal atrophy in subcortical ischaemic vascular dementia. Neurol Sci (2004) 0.83

Double dissociation between temporal and spatial pattern processing in patients with frontal and parietal damage. Cortex (1990) 0.83

A recombinant human 'mini'-hexokinase is catalytically active and regulated by hexose 6-phosphates. Biochem J (1992) 0.83

Behavior of soluble intercellular adhesion molecule-1 and endothelial-leukocyte adhesion molecule-1 concentrations in patients with Graves' disease with or without ophthalmopathy and in patients with toxic adenoma. J Clin Endocrinol Metab (1995) 0.83

Biosynthesis of alpha-N-acetylglucosaminidase in cultured human kidney carcinoma cells. Enzyme (1985) 0.83